These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 8136085)

  • 1. Psychopharmacological Treatment, Intraocular Pressure and the Risk of Glaucoma: A Review of Literature.
    Ciobanu AM; Dionisie V; Neagu C; Bolog OM; Riga S; Popa-Velea O
    J Clin Med; 2021 Jun; 10(13):. PubMed ID: 34209089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Use of Antidepressants in Patients with Heart Failure.
    Alsumih N; Alqahtani R; Almutairi F; Faraj R; Alsubeai T; Alghanim A; Alharbi S; Almodaimegh H
    J Saudi Heart Assoc; 2020; 32(1):46-51. PubMed ID: 33154891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Metabolites of Antidepressants in the Treatment of Depression.
    Rudorfer MV; Potter WZ
    CNS Drugs; 1997 Apr; 7(4):273-312. PubMed ID: 27520753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bupropion use and risk of open-angle glaucoma among enrollees in a large U.S. managed care network.
    Stein JD; Talwar N; Kang JH; Okereke OI; Wiggs JL; Pasquale LR
    PLoS One; 2015; 10(4):e0123682. PubMed ID: 25875446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clomipramine treatment and repeated restraint stress alter parameters of oxidative stress in brain regions of male rats.
    Balk Rde S; Bridi JC; Portella Rde L; Carvalho NR; Dobrachinski F; da Silva MH; Amaral GP; Dias GR; Barbosa Nde V; Soares FA
    Neurochem Res; 2010 Nov; 35(11):1761-70. PubMed ID: 20694755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of mirtazapine on indomethacin-induced ulcer in rats and its relationship with oxidant and antioxidant parameters.
    Bilici M; Ozturk C; Dursun H; Albayrak F; Saglam MB; Uyanik A; Gulaboglu M; Tekin SB
    Dig Dis Sci; 2009 Sep; 54(9):1868-75. PubMed ID: 19034656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced urinary retention: incidence, management and prevention.
    Verhamme KM; Sturkenboom MC; Stricker BH; Bosch R
    Drug Saf; 2008; 31(5):373-88. PubMed ID: 18422378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and weight effects of open-label lamotrigine with and without concomitant psychotropic medications in patients with bipolar I disorder.
    Zarzar MN; Graham J; Roberts J; Thompson T; Nanry K
    MedGenMed; 2007 May; 9(2):41. PubMed ID: 17955096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoxetine: a review of its therapeutic potential in the treatment of depression associated with physical illness.
    Cheer SM; Goa KL
    Drugs; 2001; 61(1):81-110. PubMed ID: 11217873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The need for an iterative process for assessing economic outcomes associated with SSRIs.
    Skaer TL; Sclar DA; Robison LM; Galin RS
    Pharmacoeconomics; 2000 Sep; 18(3):205-14. PubMed ID: 11147388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced cognitive impairment in the elderly.
    Moore AR; O'Keeffe ST
    Drugs Aging; 1999 Jul; 15(1):15-28. PubMed ID: 10459729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of tricyclic antidepressants.
    Rudorfer MV; Potter WZ
    Cell Mol Neurobiol; 1999 Jun; 19(3):373-409. PubMed ID: 10319193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sertraline. A pharmacoeconomic evaluation of its use in depression.
    Davis R; Wilde MI
    Pharmacoeconomics; 1996 Oct; 10(4):409-31. PubMed ID: 10184609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoxetine. A pharmacoeconomic review of its use in depression.
    Wilde MI; Benfield P
    Pharmacoeconomics; 1998 May; 13(5 Pt 1):543-61. PubMed ID: 10180753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paroxetine. A pharmacoeconomic evaluation of its use in depression.
    Wilde MI; Whittington R
    Pharmacoeconomics; 1995 Jul; 8(1):62-81. PubMed ID: 10155603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A risk-benefit assessment of mirtazapine in the treatment of depression.
    Kasper S; Praschak-Rieder N; Tauscher J; Wolf R
    Drug Saf; 1997 Oct; 17(4):251-64. PubMed ID: 9352961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant use in the elderly. Current status of nefazodone, venlafaxine and moclobemide.
    Goldberg RJ
    Drugs Aging; 1997 Aug; 11(2):119-31. PubMed ID: 9259175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in older patients with depressive illness.
    Harris MG; Benfield P
    Drugs Aging; 1995 Jan; 6(1):64-84. PubMed ID: 7696780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative tolerability profiles of the newer versus older antidepressants.
    Rudorfer MV; Manji HK; Potter WZ
    Drug Saf; 1994 Jan; 10(1):18-46. PubMed ID: 8136085
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.